Cell Source Inc (PK)
0.00 (0.0%)


Draw Mode:

Volume 0.00
Bid Price 0.45
Ask Price 0.45
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Cell Source Inc (PK) CLCS OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.45 20:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.0024 - 1.50
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.45 USD

Cell Source Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 16.74M 37.19M 6.85M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
153.00 $ - - - -

more financials information »

Cell Source (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No CLCS Message Board. Create One! See More Posts on CLCS Message Board See More Message Board Posts

Historical CLCS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.420.490.420.48605596,4880.037.14%
1 Month0.290.560.280.39084439,4390.1655.17%
3 Months0.671.000.260.381194614,931-0.22-32.84%
6 Months0.00241.500.00240.411024713,4270.447618,650.0%
1 Year0.7491.500.00240.46226269,713-0.299-39.92%
3 Years0.552.550.00241.097,154-0.10-18.18%
5 Years0.4252.550.00240.97803756,2990.0255.88%

Cell Source (PK) Description

We are engaged in the development and commercialization of the patented technology which we license. We are currently sponsoring a clinical trial in the US. Our principal operations are focused on developing innovative cell therapy products focused on the treatment of blood cancers and nonmalignant blood disorders as well as the facilitation of safer and more accessible organ transplantations.